Replies to post #10726 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

LOL—I'll update the RMF over the weekend.

[DewDiligence]

MNTA ‘ReadMeFirst’ updated:

Appellate Court finds Teva’s 2015 Copaxone patent unenforceable;
2013-2014 news flow;
bullish things for MNTA that could happen at almost any time;
handicapping FDA approval of MNTA’s Copaxone ANDA;
musings on FDA approvability of Mylan’s Copaxone ANDA;
musings on Copaxone’s US market share;
recent patent applications and overview of MNTA’s IP estate.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=90394718